Quarterly report [Sections 13 or 15(d)]

Divestitures - Narrative (Details)

v3.25.3
Divestitures - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Loss from sale of assets classified as held for sale $ (664,269) $ 2,693,562 $ (3,424,697) $ 2,896,541  
Discontinued Operations, Held-for-Sale | Corporate Clinics          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Clinics expected to sell, period     1 year    
Estimated fair value of clinics held for sale 6,600,000   $ 6,600,000    
Valuation allowance 5,979,122   5,979,122   $ 5,071,603
Pre-tax income of clinics held for sale 900,000 400,000 3,300,000 2,900,000  
Discontinued Operations, Held-for-Sale | Corporate Clinics | Assets held for sale          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net loss on disposition or impairment from discontinued operations 461,347 1,865,124 1,884,111 2,570,461  
Discontinued Operations, Disposed of by Sale | Corporate Clinics          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net loss on disposition or impairment from discontinued operations 22,581 $ 9,823 792,726 $ (68,880)  
Valuation allowance 1,000,000.0   1,000,000.0    
Total consideration $ 7,800,000   7,800,000    
Assets sold that were previously classified as held for sale     16,200,000    
Liabilities sold that were previously classified as held for sale     7,300,000    
Selling costs     400,000    
Loss from sale of assets classified as held for sale     $ 600,000